Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ANAC

Arctos NorthStar Acquisition (ANAC) Stock Price, News & Analysis

Arctos NorthStar Acquisition logo

About Arctos NorthStar Acquisition Stock (NASDAQ:ANAC)

Advanced Chart

Key Stats

Today's Range
$10.19
$10.19
50-Day Range
$9.68
$9.79
52-Week Range
$9.44
$10.20
Volume
705 shs
Average Volume
53,611 shs
Market Capitalization
$402.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ANAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arctos NorthStar Acquisition and its competitors with MarketBeat's FREE daily newsletter.

ANAC Stock News Headlines

Northstar Clean Technologies Inc ROOF
Metal Sky Star Acquisition Corp
Time is Running Out to Consider These 7 Stocks
7 Cheap and Good Stocks to Buy Now 💰 Discover 7 massively discounted stocks ready for growth. This free report features companies like Stock #1, a niche AI leader in voice recognition technology, and Stock #6, an energy drink company rapidly expanding across major retailers.
Northstar California Resort
Arctos Northstar Acquisition Corp
See More Headlines

ANAC Stock Analysis - Frequently Asked Questions

Arctos NorthStar Acquisition Corp. (NASDAQ:ANAC) issued its earnings results on Tuesday, May, 10th. The biopharmaceutical company reported ($0.36) EPS for the quarter, missing analysts' consensus estimates of ($0.35) by $0.01. The firm's revenue for the quarter was up 14.9% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Arctos NorthStar Acquisition investors own include Portola Pharmaceuticals (PTLA), Micron Technology (MU), Bristol Myers Squibb (BMY), bluebird bio (BLUE), Netflix (NFLX), Palo Alto Networks (PANW) and BioMarin Pharmaceutical (BMRN).

Company Calendar

Last Earnings
5/10/2016
Today
7/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
Holding & other investment offices
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:ANAC
CIK
1411158
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$7.16 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-70.78%
Return on Assets
3.97%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.15
Quick Ratio
0.15

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.18 per share
Price / Cash Flow
56.23
Book Value
($0.63) per share
Price / Book
-16.17

Miscellaneous

Outstanding Shares
39,530,000
Free Float
N/A
Market Cap
$402.81 million
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:ANAC) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners